Funded Research

The MRF has funded millions of dollars in melanoma research since 1998.

The Melanoma Research Foundation is proud to award research grants supporting the study of melanoma prevention, diagnosis and treatment across the spectrum of the disease, including cutaneous, ocular and mucosal melanoma. These include the following:

  • Team Awards (established in 2014) - Two-year awards, up to $250,000 per year
  • Established (Senior) Investigator Awards (established in 2006) - Two-year awards, up to $100,000 per year
  • Career Development (Junior) Awards (established in 1998) - Two-year awards, up to $50,000 per year
  • Medical Student Awards (established in 2011) - One-year awards, up to $3,000
  • Society for Melanoma Research Young Investigator Awards (sponsored by the MRF since 2013) - One-year awards, $5,000 per year
  • Society for Melanoma Research Christopher J. Marshall Award (sponsored by the MRF since 2015) - One-year awards, $5,000 per year

View a summary of the 2020 Research Recipients here.

Monitoring melanoma targeted therapy using microfluidic CTC-Chip

Career Development Award 2013
Principal Investigator: Dr. Xi Luo
Institution: Massachusetts General Hospital Center for Cancer


The BRAF-regulated IncRNA BANCR regulates melanoma cell migration

Career Development Award 2013
Principal Investigator: Dr. Ross Flockhart
Institution: Stanford University


Modulating immunosuppressive signals in cancer cells using FDA-approved compounds

Established Investigator Award 2013
Principal Investigator: Dr. Eduardo Davila
Institution: University of Maryland, Baltimore


Overcoming resistance to MEK inhibition in advanced uveal melanoma

Career Development Award – CURE OM 2013
Principal Investigator: Dr. Richard Carvajal
Institution: Memorial Sloan-Kettering Cancer Center

CURE OM funded


Elucidating the role of BMI1 in metastatic melanoma

Established Investigator Award 2013
Principal Investigator: Dr. Jacqueline Lees
Institution: Massachusetts Institute of Technology


Understanding and targeting ER stress pathways in melanoma

Established Investigator Award 2013
Principal Investigator: Dr. Ze'ev Ronai
Institution: Sanford-Burnham Medical Research Institute


TIGIT-mediated regulation of immune suppression in melanoma

Career Development Award 2013
Principal Investigator: Dr. Ana Anderson
Institution: Brigham and Women's Hospital

Career Development Award


Assessing TSPY as a marker for melanoma progression in men

Medical Student Award 2012
Principal Investigator: Jillian W. Wong
Institution: University of Utah Medical School

In memory of Robert Hansen and Brad Lanpher


Soluble adenylyl cyclase regulates melanoma through autophagy

Medical Student Award 2012
Principal Investigator: Adam J. Widman
Institution: Weill Cornell Medical College

Medical Student Award – In memory of Thomas Gutheil


Treatment outcomes with bevacizumab and triamcinolone for posterior uveal melanoma in patients undergoing I-125 plaque brachytherapy

Medical Student Award 2012
Principal Investigator: Nisha V. Shah
Institution: University of Miami Miller School of Medicine

Medical Student Award – In honor of participants in the Suncoast Miles for Melanoma